Memphasys Ltd (AU:MEM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Memphasys Limited (ASX: MEM), a leader in reproductive biotechnology, announced the successful outcomes of its 2024 Annual General Meeting. Key resolutions, including the election and re-election of directors and the approval of strategic mandates, were carried with strong support. This marks a positive step for the company as it continues to innovate in biotechnology applications.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.